Commercialization Transactions for Life Sciences Company
Life Sciences Company
Representation of a rapid assay diagnostics company in a series of commercialization transactions to launch a de novo medical diagnostic product. Advised on a range of agreements critical to success of the launch, including master reseller agreements, brokerage agreements, services agreements, supply chain distribution agreements, and contract manufacturing agreements.
Related Practices
MORE EXPERIENCE
Representation of B piece and special servicer clients, handling in excess of $130billion in 2.0 CMBSsecuritizations.
Representation of an energy company in its $9.45 billion all-cash acquisition of another energy company, resulting in the creation of the largest utility holding company in the United States.
Handled the sale of over 2,000 REOs, with aggregate purchase prices in the billions of dollars, through both the negotiation and closing of individual sales and the structuring and sale by auction of multiple properties. The largest was approximately $216 million, which was the sale of a major hotel...